IDEXX Laboratories Income from Continuous Operations 2010-2024 | IDXX
IDEXX Laboratories income from continuous operations for the twelve months ending September 30, 2024 was $0.866B, a 5.29% increase year-over-year.
- IDEXX Laboratories annual income from continuous operations for 2023 was $0.845B, a 24.44% increase from 2022.
- IDEXX Laboratories annual income from continuous operations for 2022 was $0.679B, a 8.83% decline from 2021.
- IDEXX Laboratories annual income from continuous operations for 2021 was $0.745B, a 27.95% increase from 2020.